{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:04:36Z","timestamp":1794870276489,"version":"4.9.1"},"reference-count":38,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Hyogo Innovative Challenge Project at Hyogo College of Medicine","award":["Hyogo Innovative Challenge Project at Hyogo Colleg"],"award-info":[{"award-number":["Hyogo Innovative Challenge Project at Hyogo Colleg"]}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K09963"],"award-info":[{"award-number":["19K09963"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2022,3,23]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To identify the risk factors and characteristics of central serous chorioretinopathy (CSC) with subsequent macular neovascularisation (MNV) detected on optical coherence tomography angiography (OCTA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>We included patients from six institutions who were initially diagnosed with CSC and subsequently did or did not develop MNV detected by OCTA. Potential influencing factors were identified by evaluating the patients\u2019 baseline demographics, multimodal fundus imaging, treatment options, recurrence and outcomes in both groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We enrolled 176 eyes in 152 patients (112 men, 40\u2009women; mean age: 52.1\u00b110.4 years) with a mean follow-up of 30.4\u00b116.3 months. Secondary MNV was present in 23 eyes (13.1%), and non-MNV was observed in 153 eyes (86.9%) by OCTA. Multivariate analysis revealed that older age (OR 1.06; 95% CI 1.01 to 1.11; p=0.014), chronic CSC (OR 3.05; 95%\u2009CI 1.12 to 8.30; p=0.029), leakage sites within the fovea on fluorescein angiography (OR 7.60; 95%\u2009CI, 1.89 to 30.48; p=0.004) and recurrent fluid within the first year (OR 5.12; 95%\u2009CI 1.66 to 15.77; p=0.012) were risk factors for subsequent MNV. Moreover, eyes with CSC complicated with MNV were characterised by poor visual acuity and low complete fluid resolution rates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The factors associated with MNV secondary to CSC were older age, higher rates of chronic CSC and recurrence, and foveal leakage points on fluorescein angiography.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2022-000976","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T12:30:10Z","timestamp":1650285010000},"page":"e000976","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Risk factors and characteristics of central serous chorioretinopathy with later development of macular neovascularisation detected on OCT angiography: a retrospective multicentre observational study"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0642-0332","authenticated-orcid":false,"given":"Xiaoyin","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan"},{"name":"Japan Clinical Retina Study (JCREST) group, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7107-6366","authenticated-orcid":false,"given":"Yuki","family":"Komuku","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan"},{"name":"Japan Clinical Retina Study (JCREST) group, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan"},{"name":"Japan Clinical Retina Study (JCREST) group, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Terasaki","sequence":"additional","affiliation":[{"name":"Japan Clinical Retina Study (JCREST) group, Kagoshima, Kagoshima, Japan"},{"name":"Department of Ophthalmology, Kagoshima University, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Miki","sequence":"additional","affiliation":[{"name":"Japan Clinical Retina Study (JCREST) group, Kagoshima, Kagoshima, Japan"},{"name":"Department of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Kuwayama","sequence":"additional","affiliation":[{"name":"Japan Clinical Retina Study (JCREST) group, Kagoshima, Kagoshima, Japan"},{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9930-7026","authenticated-orcid":false,"given":"Tomo","family":"Nishi","sequence":"additional","affiliation":[{"name":"Japan Clinical Retina Study (JCREST) group, Kagoshima, Kagoshima, Japan"},{"name":"Department of Ophthalmology, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Japan Clinical Retina Study (JCREST) group, Kagoshima, Kagoshima, Japan"},{"name":"Department of Ophthalmology, Sapporo City General Hospital, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0807-8817","authenticated-orcid":false,"given":"Fumi","family":"Gomi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan"},{"name":"Japan Clinical Retina Study (JCREST) group, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"2025090110181034000_7.1.e000976.1","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100865","article-title":"Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities","volume":"79","author":"Kaye","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"2025090110181034000_7.1.e000976.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"2025090110181034000_7.1.e000976.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.01.029"},{"key":"2025090110181034000_7.1.e000976.4","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000635"},{"key":"2025090110181034000_7.1.e000976.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.11.004"},{"key":"2025090110181034000_7.1.e000976.6","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1038\/s41433-021-01396-2","article-title":"Macular neovascularization in AMD, CSC and best vitelliform macular dystrophy: quantitative OCTA detects distinct clinical entities","volume":"35","author":"Arrigo","year":"2021","journal-title":"Eye"},{"key":"2025090110181034000_7.1.e000976.7","first-page":"9","article-title":"Multimodal imaging in the management of choroidal neovascularization secondary to central serous chorioretinopathy","volume":"2020","author":"Hagag","year":"1934","journal-title":"J Clin Med"},{"key":"2025090110181034000_7.1.e000976.8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5301\/ejo.5000036","article-title":"Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathy","volume":"22","author":"Pikkel","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"2025090110181034000_7.1.e000976.9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/IAE.0000000000000804","article-title":"Antiangiogenics in choroidal neovascularization associated with laser in central serous chorioretinopathy","volume":"36","author":"Chhablani","year":"2016","journal-title":"Retina"},{"key":"2025090110181034000_7.1.e000976.10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45080-8","article-title":"Optical coherence tomography angiography for diagnosis of choroidal neovascularization in chronic central serous chorioretinopathy after photodynamic therapy","volume":"9","author":"Wu","year":"2019","journal-title":"Sci Rep"},{"key":"2025090110181034000_7.1.e000976.11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jamaophthalmol.2015.1320","article-title":"Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography","volume":"133","author":"Bonini Filho","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"2025090110181034000_7.1.e000976.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.05.003"},{"key":"2025090110181034000_7.1.e000976.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213110","article-title":"Central serous chorioretinopathy with and without steroids: a multicenter survey","volume":"14","author":"Araki","year":"2019","journal-title":"PLoS One"},{"key":"2025090110181034000_7.1.e000976.14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-42623-x","article-title":"Optical coherence tomography angiography compared with indocyanine green angiography in central serous chorioretinopathy","volume":"9","author":"Hu","year":"2019","journal-title":"Sci Rep"},{"key":"2025090110181034000_7.1.e000976.15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2016.01.011","article-title":"Choroidal neovascularization analyzed on ultrahigh-speed swept-source optical coherence tomography angiography compared to spectral-domain optical coherence tomography angiography","volume":"164","author":"Novais","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"2025090110181034000_7.1.e000976.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.12.048"},{"key":"2025090110181034000_7.1.e000976.17","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200202000-00004"},{"key":"2025090110181034000_7.1.e000976.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30386-2"},{"key":"2025090110181034000_7.1.e000976.19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/IAE.0000000000002810","article-title":"The incidence of neovascularization in central serous chorioretinopathy by optical coherence tomography angiography","volume":"41","author":"Savastano","year":"2021","journal-title":"Retina"},{"key":"2025090110181034000_7.1.e000976.20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajo.2020.10.011","article-title":"OCT risk factors for 3-year development of macular complications in eyes with \u201cresolved\u201d chronic central serous chorioretinopathy","volume":"223","author":"Borrelli","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"2025090110181034000_7.1.e000976.21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/7217906","article-title":"Choroidal neovascularization secondary to central serous chorioretinopathy: OCT angiography findings and risk factors","volume":"2020","author":"Yeo","year":"2020","journal-title":"J Ophthalmol"},{"key":"2025090110181034000_7.1.e000976.22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10384-021-00861-5","article-title":"Clinical characteristics of central serous chorioretinopathy in patients by age","volume":"65","author":"Tanaka","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"2025090110181034000_7.1.e000976.23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ajo.2015.08.028","article-title":"Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease","volume":"160","author":"Dansingani","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"2025090110181034000_7.1.e000976.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-40406-y","article-title":"Risk factors and outcomes of choroidal neovascularization secondary to central serous chorioretinopathy","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"2025090110181034000_7.1.e000976.25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2018.06.009","article-title":"Clinical features of central serous chorioretinopathy with type 1 choroidal neovascularization","volume":"193","author":"Shiragami","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"2025090110181034000_7.1.e000976.26","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-315318"},{"key":"2025090110181034000_7.1.e000976.27","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/IAE.0b013e3182680a66","article-title":"Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration","volume":"32","author":"Fung","year":"2012","journal-title":"Retina"},{"key":"2025090110181034000_7.1.e000976.28","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000331"},{"key":"2025090110181034000_7.1.e000976.29","doi-asserted-by":"publisher","DOI":"10.1007\/BF02334172"},{"key":"2025090110181034000_7.1.e000976.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.01.021"},{"key":"2025090110181034000_7.1.e000976.31","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-311338"},{"key":"2025090110181034000_7.1.e000976.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)73524-X"},{"key":"2025090110181034000_7.1.e000976.33","first-page":"e806","article-title":"Pachychoroid spectrum disease","volume":"6","author":"Borooah","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"2025090110181034000_7.1.e000976.34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75789-w","article-title":"Quantitative measures of vortex veins in the posterior pole in eyes with pachychoroid spectrum diseases","volume":"10","author":"Matsumoto","year":"2020","journal-title":"Sci Rep"},{"key":"2025090110181034000_7.1.e000976.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.04.014"},{"key":"2025090110181034000_7.1.e000976.36","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314625"},{"key":"2025090110181034000_7.1.e000976.37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.oret.2017.01.003","article-title":"OCT angiography of treatment-na\u00efve quiescent choroidal neovascularization in pachychoroid neovasculopathy","volume":"1","author":"Carnevali","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"2025090110181034000_7.1.e000976.38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77566-1","article-title":"Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease","volume":"10","author":"Borrelli","year":"2020","journal-title":"Sci Rep"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2022-000976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:18:20Z","timestamp":1756747100000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2022-000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,4,18]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/bmjophth-2022-000976"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2022-000976","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}